Monopar Therapeutics (MNPR) insider trading
Every open-market stock purchase and sale by Monopar Therapeutics executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Chandler Robinson (CEO) and 4 others sold $4.8M in the last 90 days.
- Last insider buy: Quan Anh Vu (CFO), $105K, 10 months ago.
Last 12 months: insiders bought $105K (1 buy) and sold $5.2M (8 sales). Last close $72.58 on Oct 22, 2026.
Recent MNPR insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Oct 20, 2026 | Chandler Robinson (CEO) | Sold (not open market) | $55.3K |
| Oct 1, 2026 | Christopher M Starr (Director) | Sold | $362K |
| Oct 1, 2026 | Christopher M Starr (Director) | Sold | $234K |
| Oct 1, 2026 | Christopher M Starr (Director) | Sold | $63.7K |
| Oct 1, 2026 | Christopher M Starr (Director) | Bought (not open market) | $42 |
| Oct 1, 2026 | Christopher M Starr (Director) | Bought (not open market) | — |
| Sep 30, 2026 | Chandler Robinson (CEO) | Sold (not open market) | $346K |
| Sep 30, 2026 | Andrew Cittadine (COO) | Sold (not open market) | $155K |
| Sep 30, 2026 | Quan Anh Vu (CFO) | Sold (not open market) | $14.3K |
| Sep 30, 2026 | Quan Anh Vu (CFO) | Bought (not open market) | — |
| Sep 30, 2026 | Chandler Robinson (CEO) | Bought (not open market) | — |
| Sep 30, 2026 | Quan Anh Vu (CFO) | Bought (not open market) | — |
| Sep 30, 2026 | Andrew Cittadine (COO) | Bought (not open market) | — |
| Sep 30, 2026 | Chandler Robinson (CEO) | Bought (not open market) | — |
| Sep 30, 2026 | Andrew Cittadine (COO) | Bought (not open market) | — |
| Sep 24, 2026 | Chandler Robinson (CEO) | Sold | $911K |
| Sep 24, 2026 | Chandler Robinson (CEO) | Sold | $848K |
| Sep 24, 2026 | Chandler Robinson (CEO) | Sold | $745K |
| Sep 24, 2026 | Chandler Robinson (CEO) | Bought (not open market) | $422K |
| Sep 24, 2026 | Chandler Robinson (CEO) | Bought (not open market) | $210K |
| Sep 24, 2026 | Chandler Robinson (CEO) | Sold | $53.9K |
| Sep 24, 2026 | Chandler Robinson (CEO) | Bought (not open market) | — |
| Sep 24, 2026 | Chandler Robinson (CEO) | Bought (not open market) | — |
| Aug 26, 2026 | Kim R Tsuchimoto (Director) | Sold | $123K |
| Aug 26, 2026 | Kim R Tsuchimoto (Director) | Sold | $123K |
Who's trading MNPR
- Chandler Robinson, CEO: sold $2.6M (4 sales), last Oct 20, 2026
- Christopher M Starr, Director: sold $659K (3 sales), last Oct 1, 2026
- Quan Anh Vu, CFO: bought $105K (1 buy), last Sep 30, 2026
- Andrew Cittadine, COO: other filings, last Sep 30, 2026
- Patrice Rioux, Insider: sold $111 (1 sale), last Aug 26, 2026
- Kim R Tsuchimoto, Director: sold $911K (12 sales), last Aug 26, 2026
- Raymond Anderson, Director: sold $703K (6 sales), last Aug 25, 2026
- Nicole Sweeny, Director: other filings, last Jun 26, 2026
- Susan Rodriguez, Officer: other filings, last Mar 2, 2026
- Arthur J Klausner, Director: sold $344K (2 sales), last Dec 18, 2025
- Diane Hendricks, 10% owner: other filings, last Dec 16, 2025
- Lavina Talukdar, Director: other filings, last Dec 2, 2025
Get free alerts when an insider at Monopar Therapeutics files a new trade →